Cypress Capital, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1729939 FRANKLIN, TN

Position in GILD

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$284,770

-$18,917 QoQ

Shares Held

2,254

+3.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#1,682

of 2,266 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cypress Capital, LLC holds $13,403,943 across 6 Drug Manufacturers - General names. GILD ranks #6 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	13,964	$3,513,900
2	MRK	Merck & Co., Inc.	24,880	$3,197,080
3	AMGN	Amgen Inc	8,112	$2,937,517
4	BMY	Bristol Myers Squibb Co	44,705	$2,575,902
5	LLY	ELI LILLY & Co	746	$894,774
6	GILD	Gilead Sciences, Inc. This page	2,254	$284,770

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$284,770	2,254	+3.4%	Shares	Sole	2026-07-17
2026-03-31	$303,687	2,179	+0.6%	Shares	Sole	2026-04-28
2025-12-31	$265,977	2,167	+2.8%	Shares	Sole	2026-02-06
2025-09-30	$233,877	2,107	-4.8%	Shares	Sole	2025-10-23
2025-06-30	$245,466	2,214	+16930.8%	Shares	Sole	2025-08-07
2024-06-30	$891	13	-99.6%	Shares	Sole	2024-08-22
2021-12-31	$220,008	3,030	-5.6%	Shares	Sole	2022-02-10
2021-09-30	$224,218	3,210	+106900.0%	Shares	Sole	2022-02-10
2021-06-30	$206	3	0.0%	Shares	Sole	2021-08-16
2021-03-31	$193	3	-100.0%	Shares	Sole	2021-05-17
2020-06-30	$1,738,459	22,595	—	Shares	Sole	2020-08-20
No filing history on record for this holder in this stock.